Metoprolol Succinate Tablet, Film Coated, Extended Release
Product Images NDC 82804-252

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 82804-252). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

82804-252-90 (Image 01)

Label for Metoprolol Succinate 25 mg Extended Release (E.R.) Tablets, film-coated, oval, biconvex, with breakline and debossed markings. Package contains 90 tablets. Manufactured by Alkem Laboratories Ltd., India, and packaged by Proficient Rx LP, Thousand Oaks, CA. Includes NDC 82804-252-90 and storage instructions at 25°C (77°F).*

FDA Label Image

Metoprolol-structure (Metoprolol Structure)

Chemical structure of Metoprolol Succinate, showing the molecular arrangement including aromatic ring, alcohol group, and succinate moiety as part of the extended release tablet formulation.*

FDA Label Image

Metoprolol-table1a (Metoprolol Table1a)

A forest plot showing results for subgroups in the MERIT-HF study. The graph displays relative risk and 95% confidence intervals for three outcomes: total mortality, total mortality or all-cause hospitalization, and total mortality or hospitalization for heart failure, comparing Metoprolol Succinate Extended-Release Tablets to placebo across various patient subgroups. Subgroups include US vs. Non-US, NYHA class, ejection fraction levels, etiologies, sex, race, history of myocardial infarction, diabetes status, hypertension history, and heart rate categories.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.